MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression.
By: Lei Chen, Xiang-Rong Chen, Run Zhang, Peng Li, Yi Liu, Ke Yan, Xiao-Dan Jiang

The National Key Clinic Specialty, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of Neurosurgery, The Neurosurgery Institute of Guangdong Province, Zhujiang Hospital, Southern Medical University, 253# Gongye Road, Guangzhou, 510282, China.
2012-9-18; doi: 10.1007/s11060-012-1037-7
Abstract

MicroRNAs (miRNAs), small non-protein-coding RNA molecules, modulate target gene expression by binding to 3'untranslated regions (UTR) of target mRNA. These molecules are aberrantly expressed in many human cancers, and can function either as tumor suppressors or oncogenes. In the current study, we show that miR-107 is down-regulated in glioma tissues and cell lines, and its overexpression leads to inhibition of the migratory and invasive ability of glioma cells via direct targeting of Notch2, which is known to transactivate Tenascin-C and Cox-2. Experiments with Notch2 siRNA further suggest that miR-107 may exerts its anti-invasive activity through Notch2 signaling pathways. Our findings collectively indicate that miR-107 is involved in glioma cell migration and invasion, and support its utility as a potential target for glioma treatment.





PMID:23299462






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements